USPTO serial 88585991
VITALTRACE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 23, 2021
- Examiner
- PORTARO, ALEXANDRA J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with VITALTRACE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Marlene J. Williams
Marlene J. Williams Buchalter, A Professional Corporation425 Market Street, Suite 2900San Francisco, CA 94105UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical devices, namely, medical ultrasound apparatus, heart monitors, patient monitoring sensors and alarms, medical devices for monitoring vital signs, blood properties and respiratory events, fetal and maternal vital sign and physical distress monitors, and parts and fittings therefor; medical and surgical apparatus, namely, medical ultrasound apparatus, heart monitors, patient monitoring sensors and alarms, medical devices for monitoring vital signs, blood properties and respiratory events, fetal and maternal vital sign and physical distress monitors, and parts and fittings therefor; scientific, optical, diagnostic, analysing, measuring, monitoring, observation and checking (supervision) apparatus, namely, medical ultrasound apparatus, heart monitors, patient monitoring sensors and alarms, medical devices for monitoring vital signs, blood properties and respiratory events, fetal and maternal vital sign and physical distress monitors, and parts and fittings therefor; equipment and instruments for medical use and medical purposes, namely, medical ultrasound apparatus, heart monitors, patient monitoring sensors and alarms, medical devices for monitoring vital signs, blood properties and respiratory events, fetal and maternal vital sign and physical distress monitors, and parts and fittings therefor; apparatus, equipment and instruments for medical purposes, namely, medical imaging apparatus; medical apparatus, equipment and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit, for patient diagnosis, patient care patient management, exchanging communications, and electronically storing data and other digital content; equipment and instruments for medical purposes, namely, biosensors, electrochemical sensors, optical sensors, lactate sensors, pH sensors, pulse oximetry, scalp fixation devices, electronic leads, reference electrodes, wet electrodes, fetal scalp lead, controllers for use in direct association with medical diagnosis apparatus during the process of diagnosis of a condition in an individual; medical obstetric apparatus for fetal monitoring, maternal monitoring, detection of birthing complications; diagnostic apparatus for obstetrics, namely, medical diagnostic devices for fetal monitoring, maternal monitoring, monitoring during labour, monitoring after labour, monitoring neonatal well-being; research instruments for medical diagnosis in the nature of medical devices for studying fetal physiology in human and animal research, medical devices for studying animal well-being in a research setting, medical devices for studying animal well-being in livestock; monitoring apparatus for medical use, namely, medical apparatus for monitoring acidemia in patients, medical apparatus for monitoring critically ill patients, medical apparatus for monitoring septic patients, medical apparatus for detecting surgical complications | ACTIVE | — |
| 042 | Medical research; Scientific research relating to medicine; design of medical apparatus; research and development of products; advisory services relating to scientific and technological research in the field of medical monitoring and diagnosis; providing information and providing a website featuring information in the field of scientific and technological services and research and design relating to medical devices; Medical research in the nature of preparation of reports relating to scientific and technological medical research; development of computer software; software creation, namely, design and development of computer software; installation, repair and maintenance of middleware computer software; computer software advisory services; software engineering; design and development of systems for the processing, storage and transmission of data; technical data analysis services, namely, providing temporary use of online non-downloadable software that enables users to analyze patient data in real-time and for providing reports to clinicians | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vitaltrace Pty Ltd
- Other trademarks owned by Vitaltrace Pty Ltd
- Other trademarks owned by Vitaltrace Pty Ltd
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named VITALTRACE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 23, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 9, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 9, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 9, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 1, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 1, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 23, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 8, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 8, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 18, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 1, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 1, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 1, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 1, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 1, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 27, 2020 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Aug 27, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jul 26, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 26, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 26, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 5, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 5, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 3, 2020 | ALIE | ASSIGNED TO LIE | — |
| May 26, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 26, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 26, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 26, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 19, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 5, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 23, 2019 | NWAP | NEW APPLICATION ENTERED | — |